Godsey & Gibb Inc’s Sanofi SNY Stock Holding History

Godsey & Gibb Inc’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-164	Closed	-$9.45K	–	430
2024 Q3	$9.45K	Buy	+164	New	+$8.85K	﹤0.01%	328

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Godsey & Gibb Inc's SNY Position: Q4 2024 in Review

Godsey & Gibb Inc sold out of Sanofi (SNY) in Q4 2024, closing a stake of 164 shares — an estimated $9.45K sold.

Godsey & Gibb Inc first reported a position in SNY in Q3 2024 and held it in 1 quarter. The position peaked at $9.45K in Q3 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

Godsey & Gibb Inc reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
Godsey & Gibb Inc sold 164 Sanofi shares in Q4 2024, an estimated $9.45K.
Godsey & Gibb Inc first reported a position in Sanofi in Q3 2024 and held it in 1 quarter.
Godsey & Gibb Inc's Sanofi position peaked at $9.45K in Q3 2024.
730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Godsey & Gibb Inc's 13F filing for Q4 2024, filed 14 Jan 2025.